This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Baylor College of Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kurt Bohren: Inventor of a Direct Thrombin Inhibitor Patent.
Introduction
Kurt Bohren is an inventor associated with Houston, Texas, and Baylor College of Medicine. His patent work concerns compounds intended to inhibit thrombin, a target relevant to blood clotting.
Latest Patents
Bohren is associated with 1 patent, titled “Direct Thrombin Inhibitors and Methods of Use Thereof.” The patent describes novel direct thrombin inhibitors and methods for using them as anticoagulants. It also discusses their potential use in treating or preventing thromboembolism and bleeding or clotting disorders, as well as methods for inhibiting thrombin in cells.
Career Highlights
Bohren’s listed patent reflects research focused on therapeutic compounds and their potential applications in managing clotting-related conditions. His association with Baylor College of Medicine connects this work to a medical research institution.
Collaborations
John Faver is identified as a coworker associated with Bohren.
Conclusion
Kurt Bohren’s patent work centers on direct thrombin inhibitors and their potential use in addressing thromboembolism and other bleeding or clotting disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile